Drugs Made In America Acquisition II Corp. (DMIIU) Accounts Payables (2025)

Drugs Made In America Acquisition (DMIIU) has reported Accounts Payables for 1 consecutive years, with $99359.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Accounts Payables changed N/A year-over-year to $99359.0; the TTM figure through Dec 2025 stood at $99359.0 (changed N/A YoY), while the FY2025 annual figure was $99359.0, changed N/A from the prior year.
• Accounts Payables advanced to $99359.0 in Q4 2025 per DMIIU's latest filing, from $4592.0 in the prior quarter.
• Across five years, Accounts Payables topped out at $99359.0 in Q4 2025 and bottomed at $4592.0 in Q3 2025.